
Viyash Scientific Completes Acquisition of BioForLife Italia S.r.l.
Viyash Scientific Limited announced the completion of its acquisition of 100% share capital of BioForLife Italia S.r.l. (BFL Italy) through its step-down wholly owned subsidiary, Alivira Animal Health Limited, Ireland. The acquisition was finalized on October 1, 2026, as per the Sale and Purchase Agreement dated July 21, 2026. BFL Italy now becomes a step-down wholly owned subsidiary of Viyash Scientific. The base purchase consideration is EUR 15.0 million plus the agreed reference net financial position as of June 30, 2026. An additional EUR 1.976 million is payable as deferred consideration, subject to adjustments based on the net financial position as of the closing date. Representatives from Alivira Animal Health have been appointed to the Board of BFL Italy.
Key Highlights
- Acquisition of 100% share capital of BioForLife Italia S.r.l. completed.
- Transaction executed via step-down subsidiary Alivira Animal Health Limited.
- Base consideration: EUR 15.0 million plus net financial position.
- Deferred consideration of EUR 1.976 million subject to adjustments.
- BFL Italy is now a step-down wholly owned subsidiary.
Price Impact
More from VIYASH